Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 4, 2025. The detailed results of the votes received by proxy are as follows:
Election of Directors
|
Director Nominees |
NUMBER OF SHARES |
PERCENTAGE OF VOTES CAST |
||
|
FOR |
WITHHELD |
FOR |
WITHHELD |
|
|
Daniel N. Chicoine |
5,432,232 |
301,172 |
94.75% |
5.25% |
|
Anthony E. Dobranowski |
5,455,219 |
278,185 |
95.15% |
4.85% |
|
John C. London |
5,427,266 |
306,138 |
94.66% |
5.34% |
|
Deborah Shannon-Trudeau |
5,463,225 |
270,179 |
95.29% |
4.71% |
|
Serge Verreault |
5,490,982 |
242,422 |
95.77% |
4.23% |
Reappointment of External Auditors
|
Outcome |
NUMBER OF SHARES |
PERCENTAGE OF VOTES CAST |
||
|
FOR |
WITHHELD |
FOR |
WITHHELD |
|
|
Ernst & Young LLP reappointed |
6,388,758 |
49,767 |
99.23% |
0.77% |
Approval of the Continuation of Crescita’s Shareholder Rights Plan
|
Outcome |
NUMBER OF SHARES |
PERCENTAGE OF VOTES CAST |
||
|
FOR |
AGAINST |
FOR |
AGAINST |
|
|
Shareholder Rights Plan approved |
5,481,368 |
252,036 |
95.60% |
4.40% |
About Crescita Therapeutics Inc.
Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The Company offers a portfolio of high-quality, science-based non-prescription skincare products and a commercial stage prescription product. We also own multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. For more information visit, www.crescitatherapeutics.com.
Source: Crescita Therapeutics
View source version on businesswire.com: https://www.businesswire.com/news/home/20250605776909/en/
Distribution channels:
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release